Yung Zip Chemical Ind. Co., Ltd. (TPEX:4102)
Taiwan
· Delayed Price · Currency is TWD 23.05
+0.10 (0.44%)
Apr 24, 2025, 1:30 PM CST
Yung Zip Chemical Ind. Revenue
In the year 2024, Yung Zip Chemical Ind. had annual revenue of 583.70M TWD with 4.39% growth. Yung Zip Chemical Ind. had revenue of 102.27M in the quarter ending December 31, 2024, a decrease of -31.81%.
Revenue
583.70M
Revenue Growth
+4.39%
P/S Ratio
1.67
Revenue / Employee
3.09M
Employees
189
Market Cap
972.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 583.70M | 24.54M | 4.39% |
| Dec 31, 2023 | 559.15M | -8.18M | -1.44% |
| Dec 31, 2022 | 567.33M | 89.74M | 18.79% |
| Dec 31, 2021 | 477.60M | 14.38M | 3.11% |
| Dec 31, 2020 | 463.21M | 46.38M | 11.13% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |